Skip to main content
Zofia Piotrowska, MD, Oncology, Boston, MA, Massachusetts General Hospital

ZofiaPiotrowskaMD

Oncology • Boston, MA

Clinical Instructor in Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Piotrowska is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Piotrowska's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
  • Yale School of Medicine
    Yale School of MedicineClass of 2008

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2010 - 2025

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Oxford University Press Has Registered This DOI Pre-Publication  
    R S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
  • EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas  
    Lecia V Sequist, Zofia Piotrowska, Clinical Cancer Research

Lectures

  • Clinical outcomes of EGFR+ NSCLC pts treated with immune checkpoint inhibitors (ICI). 
    2019 ASCO Annual Meeting - 6/1/2019
  • Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Highlights at ASCO22: Advancements in NSCLC Therapies
    Highlights at ASCO22: Advancements in NSCLC TherapiesJune 24th, 2022
  • Therapeutic Advances for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations
    Therapeutic Advances for Metastatic NSCLC with EGFR Exon 20 Insertion MutationsJuly 1st, 2021
  • Clinical Challenge: Optimal Therapies for Rare EGFR Mutations in NSCLC
    Clinical Challenge: Optimal Therapies for Rare EGFR Mutations in NSCLCJune 22nd, 2021
  • Join now to see all

Other Languages

  • French, Polish

Hospital Affiliations

Dr. Zofia Piotrowska, Dr. Zofia Piotrowska, MD, Dr. Z Piotrowska